An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 29, Issue 4, Pages 777-782
Publisher
Wiley
Online
2014-09-03
DOI
10.1111/jdv.12678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study
- (2014) A.J. Kanwar et al. BRITISH JOURNAL OF DERMATOLOGY
- Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab
- (2013) Isabela Soubhia Corral et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximab
- (2013) Y. A. Leshem et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities
- (2013) H.H. Cho et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
- (2013) N. Colliou et al. Science Translational Medicine
- Adjuvant Rituximab Therapy of Pemphigus
- (2012) Luisa Lunardon et al. ARCHIVES OF DERMATOLOGY
- Rituximab treatment of severe pemphigus: Long-term results including immunologic follow-up
- (2012) Ziad Reguiai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Clinical efficacy of different doses of rituximab in the treatment of pemphigus: a retrospective study of 27 patients
- (2011) J.H. Kim et al. BRITISH JOURNAL OF DERMATOLOGY
- Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris
- (2011) M. Behzad et al. BRITISH JOURNAL OF DERMATOLOGY
- Low-dose rituximab is effective in pemphigus
- (2011) B. Horváth et al. BRITISH JOURNAL OF DERMATOLOGY
- Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients
- (2011) Michael Kasperkiewicz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of rituximab treatment in Indian pemphigus patients
- (2011) A.J. Kanwar et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Pemphigus vulgaris - still a difficult disease to treat
- (2010) Nuno Menezes et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Rituximab in refractory pemphigus vulgaris
- (2008) M. Sorce et al. Dermatologic Therapy
- Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab
- (2008) Martin Pfütze et al. DERMATOLOGY
- Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
- (2008) Dedee F. Murrell et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now